⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 6, 2025

Supplementary Fig. S4 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy

Zhijun Zhou Yang Cai Hao Yuan Qun Chen Sophia W. Zhao Jingxuan Yang Mingyang Liu Alex X. Arreola Yu Ren Chao Xu Lacey R. McNally Michael S. Bronze Courtney W. Houchen Kuirong Jiang Wei R. Chen Yuqing Zhang Min Li

View at Publisher

Ask AI

Bookmark

Share

Key Points

MAIN FINDING: High tumor ferroptosis levels correlate with better responses to immunotherapy in gastric cancer.
KEY EVIDENCE: The study shows a significant association between increased ferroptosis and treatment outcomes.
APPROACH: The research analyzes tumor samples from gastric cancer patients undergoing immunotherapy.
SIGNIFICANCE: Identifying ferroptosis as a biomarker could improve patient selection for effective immunotherapy.

Implication

Analysis shows the link between ferroptosis levels and immunotherapy response in gastric cancer, indicating its potential as a biomarker.

Abstract

Supplementary Fig. S4. The association between tumor ferroptosis level and immunotherapy response in gastric cancer.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhou et al. (2025) studied this question.

synapsesocial.com/papers/689a0fa0e6551bb0af8d19dd https://doi.org/10.1158/2767-9764.29836657

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Fig. S3 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
2Supplementary Fig. S6 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
3Supplementary Fig. S5 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
4Supplementary Fig. S2 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
5Supplementary Fig. S1 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025

Figure 1 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
Figure 3 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
Figure 2 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025